As a Spin-Off of the Federal Institute of Technology in Zürich, we have strong ties to academia and benefit from an advanced support structure.

At Ariya Bio, we are committed to diversity, equity, and inclusion, and we believe that a diverse team is essential to push the boundaries of what is possible in the field of genetic engineering.

We are excited about the potential of our therapies to transform the lives of patients worldwide. Our goal is to bring cutting-edge therapeutics to patients around the world and to improve health outcomes for those affected. We are committed to working collaboratively with patients, families, and healthcare providers to ensure that our therapies meet their needs and expectations.